跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,080 条关于
“Altamira Medica AG”
全部
12,080
临床试验
6,900
药物
1,160
机构
2,305
资讯
1,715
5个月前
Altamira Therapeutics Expands Nucleic Acid Delivery Platform with DNA Technology and Advances Spin-off Plans
10个月前
Altamira Therapeutics Expands xPhore Platform with Successful DNA Delivery Technology
去年
Altamira Therapeutics Partners with Undisclosed Company to Advance Circular RNA Delivery Platform
去年
Altamira Therapeutics Partners with Radiopharmaceutical Company to Enhance Cancer Treatment Targeting
9个月前
Altamira Therapeutics Secures China Approval for Bentrio Nasal Spray in Allergic Rhinitis Market
去年
Altamira Therapeutics Advances RNA Delivery Platform Through Strategic Spin-Off and Circular RNA Innovation
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
2年前
4SC AG Receives MHRA Waiver for Resminostat in Pediatric CTCL
3年前
4SC's Resminostat Advances Towards European Market Approval for CTCL Maintenance Therapy
第 1 页,共 172 页
上一页
下一页